Primary Systemic (AL) Amyloidosis
1 clinical trials · Condition
◉ Watch Primary Systemic (AL) Amyloidosis
| Record | Firm | Date |
|---|---|---|
| The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis (NCT02312206) | Prothena Biosciences Ltd. | 2015-02-01 |
Track Primary Systemic (AL) Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.